ETODOLAC- etodolac capsule

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Active ingredient:

ETODOLAC (UNII: 2M36281008) (ETODOLAC - UNII:2M36281008)

Available from:

PD-Rx Pharmaceuticals, Inc.

INN (International Name):

ETODOLAC

Composition:

ETODOLAC 300 mg

Administration route:

ORAL

Prescription type:

PRESCRIPTION DRUG

Therapeutic indications:

Carefully consider the potential benefits and risks of etodolac capsules and tablets and other treatment options before deciding to use etodolac capsules and tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Etodolac Capsules and Tablets are indicated: - For acute and long-term use in the management of signs and symptoms of the following: Osteoarthritis Rheumatoid arthritis - Osteoarthritis - Rheumatoid arthritis - For the management of acute pain Etodolac Capsules and Tablets are contraindicated in patients with known hypersensitivity to etodolac or other ingredients in etodolac. Etodolac Capsules and Tablets should not be given to patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients (see WARNINGS, Anaphylactoid Reactions and PRECAUTIONS, Pre-exist

Product summary:

Etodolac Capsules, USP 300 mg capsules (light pink gelatin capsule, with black imprint "ETO 300 MG" on cap and body, white to off-white powder filling) Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature] protected from moisture .

Authorization status:

Abbreviated New Drug Application

Patient Information leaflet

ETODOLAC- ETODOLAC CAPSULE
PD-Rx Pharmaceuticals, Inc.
----------
MEDICATION GUIDE FOR NONSTEROIDAL ANTI-
INFLAMMATORY DRUGS (NSAIDS)
What is the most important information I should know about medicines
called Nonsteroidal Anti-
inflammatory Drugs (NSAIDs)?
NSAIDs can cause serious side effects, including:
•
Increased risk of a heart attack or stroke that can lead to death.
This risk may happen early in
treatment and may increase:
•
with increasing doses of NSAIDs
•
with longer use of NSAIDs
Do not take NSAIDs right before or after a heart surgery called a
"coronary artery bypass graft
(CABG)."
Avoid taking NSAIDs after a recent heart attack, unless your
healthcare provider tells you to. You
may have an increased risk of another heart attack if you take NSAIDs
after a recent heart attack.
•
Increased risk of bleeding, ulcers, and tears (perforation) of the
esophagus (tube leading from the
mouth to the stomach), stomach and intestines:
•
anytime during use
•
without warning symptoms
•
that may cause death
The risk of getting an ulcer or bleeding increases with:
•
past history of stomach ulcers, or stomach or intestinal bleeding with
use of NSAIDs
•
taking medicines called "corticosteroids", "anticoagulants", "SSRIs",
or
"SNRIs"
•
increasing doses of NSAIDs
•
longer use of NSAIDs
•
smoking
•
drinking alcohol
•
older age
•
poor health
•
advanced liver disease
•
bleeding problems
NSAIDs should only be used:
•
exactly as prescribed
•
at the lowest dose possible for your treatment
•
for the shortest time needed
What are NSAIDs?
NSAIDs are used to treat pain and redness, swelling, and heat
(inflammation) from medical conditions
such as different types of arthritis, menstrual cramps, and other
types of short-term pain.
Who should not take NSAIDs?
Do not take NSAIDs:
•
if you have had an asthma attack, hives, or other allergic reaction
with aspirin or any other
NSAIDs.
•
right before or after heart bypass surgery.
Before taking NSAIDs, tell your healthcare provider about all of

Summary of Product characteristics

ETODOLAC- ETODOLAC CAPSULE
PD-RX PHARMACEUTICALS, INC.
----------
ETODOLAC CAPSULES AND TABLETS, USP
RX ONLY
CARDIOVASCULAR THROMBOTIC EVENTS
Nonsteroidal anti-inflammatory drugs (NSAIDs) cause an increased risk
of serious
cardiovascular thrombotic events, including myocardial infarction and
stroke, which can be
fatal. This risk may occur early in treatment and may increase with
duration of use [see
_Warnings and Precautions_].
Etodolac capsules, 200 mg and 300 mg, and Etodolac tablets, 400 mg and
500 mg are
contraindicated in the setting of coronary artery bypass graft (CABG)
surgery [see
_Contraindications_ and _Warnings_].
GASTROINTESTINAL RISK
NSAIDs cause an increased risk of serious gastrointestinal adverse
events including bleeding,
ulceration, and perforation of the stomach or intestines, which can be
fatal. These events can
occur at any time during use and without warning symptoms. Elderly
patients are at greater risk
for serious gastrointestinal (GI) events. (See WARNINGS).
DESCRIPTION
Etodolac capsules and tablets, USP are members of the pyranocarboxylic
acid group of nonsteroidal
anti-inflammatory drugs (NSAIDs). Each tablet and capsule contains
etodolac for oral administration.
Etodolac is a racemic mixture of [+]S and [-]R-enantiomers. Etodolac
is a white crystalline compound,
insoluble in water but soluble in alcohols, chloroform, dimethyl
sulfoxide, and aqueous polyethylene
glycol.
The chemical name is (±)
1,8-diethyl-1,3,4,9-tetrahydropyrano-[3,4-b]indole-1-acetic acid. The
molecular weight of the base is 287.37. It has a pKa of 4.65 and an
n-octanol: water partition coefficient
of 11.4 at pH 7.4. The molecular formula for etodolac is C
H
NO
, and it has the following
structural formula:
_Each Capsule, for oral administration, contains 200 or 300 mg of
Etodolac. In addition, each capsule_
_contains the following inactive ingredients:_ Ammonium Hydroxide USP,
Black Iron Oxide USP, Colloidal
Silicone Dioxide NF, Erythrosine (200 mg only), Ethyl Alcohol USP,
Gelatin, Isopropyl Alcohol USP,
Lactose